Head & Neck Cancers | Specialty

Promoting HPV Vaccination for Girls and Boys

September 10th 2013

Oncology nurses can lead the way in efforts to protect the next generation from this type of cancer if they know the facts about HPV vaccination for both girls and boys

Dr. Vokes on HPV-Related Head and Neck Cancer

August 29th 2013

Everett E. Vokes, MD, Giant of Cancer Care in the Head and Neck Cancer Category, John E. Ultmann Professor of Medicine and Radiation Oncology, Physician-in-Chief, University of Chicago Medicine and Biological Sciences, discusses HPV-related head and neck cancer

Sorafenib Receives Priority Review for Rare Thyroid Cancer

August 27th 2013

The FDA has given priority review designation to sorafenib for the treatment of locally advanced or metastatic RAI-refractory differentiated thyroid cancer.

Antibodies for Common HPV Strain Found in One-Third of Patients with Oropharyngeal Cancer

July 24th 2013

Approximately one-third of cases of oropharyngeal cancer carried antibodies to one of the driver proteins from HPV16, and those antibodies could be detected more than 10 years prior to the diagnosis of the cancer.

Oropharyngeal Cancer

July 23rd 2013

More is now known about the types of HPV that increase risk.

Dr. D'Souza on Screening for HPV-Related Cancers

July 22nd 2013

Gypsyamber D'Souza, PhD, MPH, MS, an associate professor of epidemiology at Johns Hopkins University, comments on screening for HPV-related cancers.

Personalizing Treatment for HPV-Related Head and Neck Cancer

July 22nd 2013

Over the past decade, it has become apparent that head and neck squamous cell carcinoma-including cancers of the mouth, throat, and larynx-is actually two separate diseases.

Conclusion: Key Take-Away Points and Final Thoughts

July 16th 2013

Therapies in Development for Medullary Thyroid Cancer

July 16th 2013

Treatment-Related Toxicity in Advanced MTC

July 16th 2013

Mutations and Targeted Therapies in Advanced MTC

July 16th 2013

Treating Advanced Medullary Thyroid Cancer

July 16th 2013

Multidisciplinary Treatment of Medullary Thyroid Cancer

July 16th 2013

Nonsurgical Treatment Options for Early-Stage MTC

July 16th 2013

Staging of Patients With Medullary Thyroid Cancer

July 16th 2013

Genetic Testing and Screening in Advanced MTC

July 16th 2013

Genetic Testing and Screening in Medullary Thyroid Cancer

July 16th 2013

Customizing Imaging Based on Calcitonin Levels in MTC

July 16th 2013

Introduction and Overview of MTC Diagnosis Challenges

July 16th 2013

Dr. Parsa on a Trial Analyzing G-200 for Glioblastoma

July 2nd 2013

Andrew T. Parsa MD, PhD, from the University of California, San Francisco, describes the design of a trial analyzing prophage G-200 vaccine for recurrent glioblastoma multiforme.